Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast Cancer
Clinical trial NCT02903524 · UNKNOWN
Trial details
- NCT number
- NCT02903524
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2018-09-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.